Patents by Inventor Morgane Solis

Morgane Solis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260265347
    Abstract: The present patent application relates to the fields of antibodies and polyomaviruses. More specifically, the present patent application relates to a human monoclonal antibody, or antigen-binding fragment thereof, directed against a polyomavirus, in particular BKV, and that is useful in the treatment of an infection by said polyomavirus or associated-disorder thereof.
    Type: Application
    Filed: April 1, 2026
    Publication date: September 10, 2026
    Applicants: Université de Strasbourg, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, LES HOPITAUX UNIVERSITAIRES DE STRASBOURG, Université Grenoble Alpes, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, CENTRE HOSPITALIER UNIVERSITAIRE GRENOBLE ALPES
    Inventors: Pascal POIGNARD, Leonardo Sebastián DERGAN-DYLON, Marlyse BUISSON, Guy SCHOEHN, Borys PEDENKO, Samira FAFI-KREMER, Morgane SOLIS, Sophie CAILLARD-OHLMANN
  • Publication number: 20250376505
    Abstract: The present patent application relates to the fields of antibodies and polyomaviruses. More specifically, the present patent application relates to a human monoclonal antibody, or antigen-binding fragment thereof, directed against a polyomavirus, in particular BKV, and that is useful in the treatment of an infection by said polyomavirus or associated-disorder thereof.
    Type: Application
    Filed: June 7, 2024
    Publication date: December 11, 2025
    Inventors: PASCAL POIGNARD, LEONARDO SEBASTIÁN DERGAN-DYLON, MARLYSE BUISSON, GUY SCHOEHN, BORYS PEDENKO, SAMIRA FAFI-KREMER, MORGANE SOLIS, Sophie Caillard-Ohlmann
  • Publication number: 20250376504
    Abstract: The present patent application relates to the fields of antibodies and polyomaviruses. More specifically, the present patent application relates to a human monoclonal antibody, or antigen-binding fragment thereof, directed against a polyomavirus, in particular BKV, and that is useful in the treatment of an infection by said polyomavirus or associated-disorder thereof.
    Type: Application
    Filed: June 7, 2024
    Publication date: December 11, 2025
    Inventors: PASCAL POIGNARD, LEONARDO SEBASTIÁN DERGAN-DYLON, MARLYSE BUISSON, GUY SCHOEHN, BORYS PEDENKO, Samira Fafi-Kremer, Morgane Solis, Sophie Caillard-Ohlmann